...
首页> 外文期刊>Protein and peptide letters >A novel long noncoding RNA Linc-ASEN represses cellular senescence through multileveled reduction of p21 expression
【24h】

A novel long noncoding RNA Linc-ASEN represses cellular senescence through multileveled reduction of p21 expression

机译:一种新型的长度非致RNA Linc-Asen通过多尺寸的P21表达减轻细胞衰老

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Long noncoding RNAs (lncRNAs) regulating diverse cellular processes implicate in many diseases. However, the function of lncRNAs in cellular senescence remains largely unknown. Here we identify a novel long intergenic noncoding RNA Linc-ASEN expresses in prematurely senescent cells. We find that Linc-ASEN associates with UPF1 by RNA pulldown mass spectrometry analysis, and represses cellular senescence by reducing p21 production transcriptionally and posttranscriptionally. Mechanistically, the Linc-ASEN-UPF1 complex suppressed p21 transcription by recruiting Polycomb Repressive Complex 1 (PRC1) and PRC2 to the p21 locus, and thereby preventing binding of the transcriptional activator p53 on the p21 promoter through histone modification. In addition, the Linc-ASEN-UPF1 complex repressed p21 expression posttranscriptionally by enhancing p21 mRNA decay in association with DCP1A. Accordingly, Linc-ASEN levels were found to correlate inversely with p21 mRNA levels in tumors from patient-derived mouse xenograft, in various human cancer tissues, and in aged mice tissues. Our results reveal that Linc-ASEN prevents cellular senescence by reducing the transcription and stability of p21 mRNA in concert with UPF1, and suggest that Linc-ASEN might be a potential therapeutic target in processes influenced by senescence, including cancer.
机译:在许多疾病中,调节多种细胞过程的长度非编码RNA(LNCRNA)。然而,在细胞衰老中的LNCRNA的功能仍然很大程度上是未知的。在这里,我们鉴定了一种在过早衰老细胞中表达的新型长期性非编码RNA LINC-ASEN。我们发现LINC-ASEN与UPF1通过RNA下拉质谱分析辅助,并通过减少P21的转录和后认证来抑制细胞衰老。通过机械地,通过募集PolycomB压制复合物1(PRC1)和PRC2至P21基因座,通过组蛋白改性,通过募集Polycomb压抑综合体1(PRC1)和PRC2,通过组蛋白改性,通过组蛋白改性来防止转录活化剂P53对P21启动子对P21启动子的结合来进行抑制的P21转录。另外,通过增强与DCP1a相关联的P21 mRNA衰减,通过增强P21 mRNA衰减来检查lec-asen-upf1复合抑制p21表达。因此,发现含锌水平与来自患者衍生的小鼠异种移植物中的肿瘤中的P21 mRNA水平相反,在各种人类癌组织中,并且在老年的小鼠组织中,与患者衍生的小鼠异种移植物中的p21 mRNA水平相似。我们的研究结果表明,LINC-ASEN通过降低P21 mRNA与UPF1的转录和稳定性来阻止细胞衰老,并表明LINC-ASEN可能是受衰老,包括癌症的过程中的潜在治疗靶标。

著录项

  • 来源
    《Protein and peptide letters》 |2020年第6期|共18页
  • 作者单位

    Inha Univ Coll Med Dept Mol Med Incheon South Korea;

    Inha Univ Coll Med Dept Mol Med Incheon South Korea;

    Univ Cambridge Milner Therapeut Inst Cambridge England;

    Inha Univ Coll Med Dept Mol Med Incheon South Korea;

    Inha Univ Coll Med Dept Mol Med Incheon South Korea;

    Yonsei Univ Severance Hosp Dept Surg Coll Med Seoul South Korea;

    Konkuk Univ Sch Med Dept Biochem Seoul South Korea;

    Yonsei Univ Severance Hosp Dept Surg Coll Med Seoul South Korea;

    Inha Univ Med Res Ctr Coll Med Incheon South Korea;

    Korea Univ Div Life Sci Seoul South Korea;

    NIA Lab Genet &

    Genom Intramural Res Program NIH Baltimore MD 21224 USA;

    Inha Univ Coll Med Dept Mol Med Incheon South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 蛋白质;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号